fbpx

Year

2019
Er det muligt at forebygge forekomsten af astma, hvis man giver nyfødte en cocktail af gavnlige bakterier? Det kan man faktisk slet ikke udelukke, vurderer et hold danske astmaspecialister på baggrund af en forskningsartikel, de netop har publiceret i det videnskabelige tidsskrift Nature Communications. De undersøgelser, som ligger til grund for den videnskabelige artikel, er...
Lund, Sweden, 16:00 CET, November 12 2019 – BONESUPPORT™ an emerging leader in orthobiologics for the management of bone injuries, announces changes in its leadership team that will take place November 18, 2019. Fergus MacLeod starts in the position as the company´s General Manager & Executive Vice President Commercial Operations EUROW. Fergus MacLeod has more...
SNF472 significantly reduced progression of cardiovascular calcification in patients with end stage kidney disease (ESKD) receiving hemodialysis SNF472 treated patients had coronary artery calcium (CAC) volume score progression of 11% from baseline versus 20% in patients receiving placebo (P=0.016) SNF472 was well tolerated Results are remarkable as they have been achieved in patients who continued to...
Monday 18 November at 11:00 ET /16:00 GMT / 17:00 CET Sanifit will host a webcast on Monday November 18 at 11am ET / 5pm CET / 4pm GMT on the results of the international Phase 2b CaLIPSO study of lead candidate SNF472 in patients with end stage kidney disease (ESKD) on hemodialysis. Joan Perelló, CEO and Alexander M....
Lund, Sweden, 7 November 2019 08.00 am CET, – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone voids, today publishes the interim report for the third quarter 2019. BONESUPPORT’S BEST QUARTER EVER “Sales in the quarter are our highest ever, with strong growth in both Europe and the US....
10 lovende forskningstalenter kan fra i dag kalde sig Lundbeckfonden Fellows. De får hver 10 mio. kr. at forske for over de kommende fem år, og dermed har Lundbeckfonden uddelt sit største fellows-program nogensinde. Det er 13. gang, Lundbeckfonden tildeler fellowships, og også denne gang er de udpegede yngre, men veletablerede forskere på hver deres...
Stor videnskabelig undersøgelse støttet af Lundbeckfonden skal analysere genetikken bag feberkramper – og søge at besvare et spørgsmål, som længe har udfordret forskerne: Øger feberkramper risikoen for at udvikle epilepsi senere i livet? Alle forældres panikknapper begynder straks at blinke, når deres småbørn får feberkramper. Og bestemt ikke uden grund, for det er meget dramatisk....
Lund, Sweden, 12:00 pm CET, 31 October 2019 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone voids. During October, the number of shares and votes in BONESUPPORT HOLDING AB (publ) has increased with 8,125 due to the exercise of warrants. As of 31 October 2019, the number of...
Cambridge, UK and Indianapolis, US – 30 October 2019: Acacia Pharma Group plc (the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new nausea and vomiting treatments for surgical and cancer patients, announces that application has been made to Euronext Brussels for the admission of the 940,442 Ordinary Shares of...
1 2 3 14

Nyheder

Danske læger vil give spædbørn bakterier i håb om at kunne forebygge astma
14. november 2019
Lundbeckfonden tildeler rekordstort antal fellowships
6. november 2019
Feberkramper hos småbørn undersøges til bunds
1. november 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge